The ACI Respiratory Network has responded to queries and concerns raised by clinicians about the use of respiratory therapies that generate aerosolised particles by developing a range of Factsheets.
These therapies are capable of transmitting respiratory viruses including COVID-19; thus they are considered high risk.
Not all will be related to general practice; however, nebulisers might be for some practices.
High-Risk Therapies - Non-Invasive Ventilation Factsheet
High-risk Therapies - High Flow Nasal Pring Oxygen Factsheet
High-Risk Therapies - Nebulisers
Safety of Corticosteroid injections during COVID-19
Dr Joel Riley (Consultant Rheumatologist and General Physician, Dubbo) strongly advises that intra-articular, soft tissue, and perineural steroid injections should be avoided whenever possible during the COVID-19 pandemic to reduce the risk of reduced immunity to viral exposure.
At present, in his clinical practice, he is not performing or referring for any parenteral steroid injection for degenerative diseases (degenerative disc disease, trochanteric bursitis, facet joint arthropathy, etc). In inflammatory conditions (rheumatoid arthritis, lupus, gout, etc) he is attempting to use the absolute minimal steroid dose possible to get disease under control.
This is in line with the British Society of Skeletal Radiologists' advice on corticosteroid injections during the COVID-19 pandemic.
British Society of Skeletal Radiologists Report